Kevin McAllister has worked in the pharmaceutical industry for over 30 years.  Kevin joined the preclinical Nervous System research department of Sandoz and held positions of increasing responsibility up to Executive Director in Neuroscience at Novartis Institutes for Biomedical Research. Following this, Kevin worked as Principal Medical Scientific Expert in the Neuroscience Clinical Development Franchise where he contributed to projects with both pre- and post-marketing approval.  Kevin is Managing Director of Neurenable GmbH, a company dedicated to enable Neuroscience drug discovery and development. Kevin holds a PhD from the University of Wales, UK, and an MBA from the International Institute for Management Development, Lausanne, Switzerland.